496 related articles for article (PubMed ID: 16860939)
1. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
Vanni T; Sprinz E; Machado MW; Santana Rde C; Fonseca BA; Schwartsmann G
Cancer Treat Rev; 2006 Oct; 32(6):445-55. PubMed ID: 16860939
[TBL] [Abstract][Full Text] [Related]
2. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel for AIDS-associated Kaposi's sarcoma.
Dhillon T; Stebbing J; Bower M
Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatment of Kaposi's sarcoma: current status and future directions.
Lilenbaum RC; Ratner L
AIDS; 1994 Feb; 8(2):141-51. PubMed ID: 7519018
[TBL] [Abstract][Full Text] [Related]
5. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
Dezube BJ
Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
[TBL] [Abstract][Full Text] [Related]
7. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
[TBL] [Abstract][Full Text] [Related]
9. Treatments of AIDS-related Kaposi's sarcoma.
Aversa SM; Cattelan AM; Salvagno L; Crivellari G; Banna G; Trevenzoli M; Chiarion-Sileni V; Monfardini S
Crit Rev Oncol Hematol; 2005 Mar; 53(3):253-65. PubMed ID: 15718150
[TBL] [Abstract][Full Text] [Related]
10. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
11. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J
Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
14. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
[TBL] [Abstract][Full Text] [Related]
15. Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment.
Monticelli A; Lewi D; Salomon H; Pampuro S; Libonatti O; Jauregui Rueda H; Hodara V
Rev Argent Microbiol; 2000; 32(4):206-8. PubMed ID: 11149154
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies for epidemic Kaposi's sarcoma.
Aldenhoven M; Barlo NP; Sanders CJ
Int J STD AIDS; 2006 Sep; 17(9):571-8. PubMed ID: 16942647
[TBL] [Abstract][Full Text] [Related]
17. Acquired immunodeficiency syndrome-related Kaposi's sarcoma: clinical features, staging, and treatment.
Dezube BJ
Semin Oncol; 2000 Aug; 27(4):424-30. PubMed ID: 10950369
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma: advances in tumor biology and pharmacotherapy.
Sung JC; Louie SG; Park SY
Pharmacotherapy; 1997; 17(4):670-83. PubMed ID: 9250545
[TBL] [Abstract][Full Text] [Related]
19. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma: an update.
Schwartz RA
J Surg Oncol; 2004 Sep; 87(3):146-51. PubMed ID: 15334644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]